Lower solvency than 88% of companies in human health. Sector median 63.0% · 21,347 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 1,325 companies had the same profile as DR. SOFIE DE BLAUWE has now. Each dot stands for 4 companies, two years later.
95.2%
were still trading
3.2%
stopped another way
1.4%
went bankrupt
Micro
10 to 20 years old
solvency under 10%
a profit of 5% of the balance sheet or more
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,325 companies, not a prediction for DR. SOFIE DE BLAUWE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0505829066
Name after signing inVisible after signing in changes role from manager to director
Director discharge: Name hiddenVisible after signing in · General meeting of 25-10-2023 · Gazette deed
Incorporation
Founding capital of €18,600, 100 shares, €12,500 paid up · Founded by Hidden nameVisible after signing in · Name after signing inVisible after signing in appointed as manager · published on 10-12-2014 · Gazette deed
First establishment
Kleine Molenstraat 5 A, Bruges
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as DR. SOFIE DE BLAUWE: general medical practice (NACE 86210). They are comparable in size and age: total assets between €238,000 and €373,000, founded between 2014 and 2017.
What is the company number of DR. SOFIE DE BLAUWE?
The company number of DR. SOFIE DE BLAUWE is 0505.829.066. The VAT number is the same number with BE in front: BE 0505.829.066.
Where is DR. SOFIE DE BLAUWE based?
The registered office is at Kleine Molenstraat 5 A, 8380 Bruges.Company details
What does DR. SOFIE DE BLAUWE do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. SOFIE DE BLAUWE?
DR. SOFIE DE BLAUWE is a private limited company (BV).
When was DR. SOFIE DE BLAUWE founded?
DR. SOFIE DE BLAUWE was founded on 26-11-2014.
Is DR. SOFIE DE BLAUWE still active?
Yes, DR. SOFIE DE BLAUWE is an active enterprise in the KBO register.
What is the turnover of DR. SOFIE DE BLAUWE?
The turnover in financial year 2025 is ≈ €400,000. This figure is estimated from the gross margin of €260,077 and 38 comparable companies (NACE 862). It probably lies between €350,000 and €500,000.Financials
Is DR. SOFIE DE BLAUWE profitable?
In financial year 2025, DR. SOFIE DE BLAUWE made a profit of €180,359.
Where can I find the annual accounts of DR. SOFIE DE BLAUWE?
DR. SOFIE DE BLAUWE filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. SOFIE DE BLAUWE due?
DR. SOFIE DE BLAUWE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline